These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29649536)

  • 21. Modulation of pancreatic β-cells in neonatally streptozotocin-induced type 2 diabetic rats by the ethanolic extract of Momordica charantia fruit pulp.
    Hafizur RM; Kabir N; Chishti S
    Nat Prod Res; 2011 Feb; 25(4):353-67. PubMed ID: 21328131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mini-review of chemical and biological properties of polysaccharides from Momordica charantia.
    Zhang F; Lin L; Xie J
    Int J Biol Macromol; 2016 Nov; 92():246-253. PubMed ID: 27377459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Momordica charantia polysaccharides ameliorate oxidative stress, hyperlipidemia, inflammation, and apoptosis during myocardial infarction by inhibiting the NF-κB signaling pathway.
    Raish M
    Int J Biol Macromol; 2017 Apr; 97():544-551. PubMed ID: 28109806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Momordica charantia reverses type II diabetes in rat.
    Malekshahi H; Bahrami G; Miraghaee S; Ahmadi SA; Sajadimajd S; Hatami R; Mohammadi B; Keshavarzi S
    J Food Biochem; 2019 Nov; 43(11):e13021. PubMed ID: 31441956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effect of Momordica charantia fruit extract on hyperglycaemia-induced cardiac fibrosis.
    Abas R; Othman F; Thent ZC
    Oxid Med Cell Longev; 2014; 2014():429060. PubMed ID: 25371774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and biological evaluation of novel peptide MC2 analogues from Momordica charantia as potential anti-diabetic agents.
    Yang B; Li X; Zhang C; Yan S; Wei W; Wang X; Deng X; Qian H; Lin H; Huang W
    Org Biomol Chem; 2015 Apr; 13(15):4551-61. PubMed ID: 25778708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification, characterization and anti-diabetic activity of a polysaccharide from mulberry leaf.
    Zhang Y; Ren C; Lu G; Cui W; Mu Z; Gao H; Wang Y
    Regul Toxicol Pharmacol; 2014 Dec; 70(3):687-95. PubMed ID: 25455227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of a novel peach gum-derived polysaccharide on postprandial blood glucose control in streptozotocin-induced diabetic mice.
    Wang Y; Lin D; Wang X; Zhu W; Ye J; Li G; Ma Z; Deng X
    Int J Biol Macromol; 2017 May; 98():379-386. PubMed ID: 28115227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A histological study of the structural changes in the liver of streptozotocin-induced diabetic rats treated with or without Momordica charantia (bitter gourd).
    Teoh SL; Latiff AA; Das S
    Clin Ter; 2009; 160(4):283-6. PubMed ID: 19795081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidiabetic activity of mycelia selenium-polysaccharide from Catathelasma ventricosum in STZ-induced diabetic mice.
    Liu Y; Sun J; Rao S; Su Y; Li J; Li C; Xu S; Yang Y
    Food Chem Toxicol; 2013 Dec; 62():285-91. PubMed ID: 24007742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat.
    Ahmed I; Adeghate E; Sharma AK; Pallot DJ; Singh J
    Diabetes Res Clin Pract; 1998 Jun; 40(3):145-51. PubMed ID: 9716917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Momordica charantia extracts ameliorate insulin resistance by regulating the expression of SOCS-3 and JNK in type 2 diabetes mellitus rats.
    Ma C; Yu H; Xiao Y; Wang H
    Pharm Biol; 2017 Dec; 55(1):2170-2177. PubMed ID: 29110587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histological changes in the kidneys of experimental diabetic rats fed with Momordica charantia (bitter gourd) extract.
    Teoh SL; Abd Latiff A; Das S
    Rom J Morphol Embryol; 2010; 51(1):91-5. PubMed ID: 20191126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polysaccharide with antioxidant, α-amylase inhibitory and ACE inhibitory activities from Momordica charantia.
    Tan HF; Gan CY
    Int J Biol Macromol; 2016 Apr; 85():487-96. PubMed ID: 26778156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of cactus, alove veral, momorcica charantia on reducing the blood glucose of diabetic mice].
    Lin X; Shen X; Long Z; Yang Q
    Wei Sheng Yan Jiu; 2001 Jul; 30(4):203-5. PubMed ID: 12561513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunomodulatory activity and partial characterisation of polysaccharides from Momordica charantia.
    Deng YY; Yi Y; Zhang LF; Zhang RF; Zhang Y; Wei ZC; Tang XJ; Zhang MW
    Molecules; 2014 Aug; 19(9):13432-47. PubMed ID: 25178064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and anti-tumour activities of sulphated polysaccharide obtained from Momordica charantia.
    Guan L
    Nat Prod Res; 2012; 26(14):1303-9. PubMed ID: 22077268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of polysaccharides from Opuntia dillenii Haw. fruits on streptozotocin-induced diabetic rats.
    Gao J; Han YL; Jin ZY; Xu XM; Zha XQ; Chen HQ; Yin YY
    Carbohydr Polym; 2015 Jun; 124():25-34. PubMed ID: 25839790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catalytic synthesis and antioxidant activity of sulfated polysaccharide from Momordica charantia L.
    Liu X; Chen T; Hu Y; Li K; Yan L
    Biopolymers; 2014 Mar; 101(3):210-5. PubMed ID: 23765337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidiabetic activities of a cucurbitane‑type triterpenoid compound from Momordica charantia in alloxan‑induced diabetic mice.
    Jiang B; Ji M; Liu W; Chen L; Cai Z; Zhao Y; Bi X
    Mol Med Rep; 2016 Nov; 14(5):4865-4872. PubMed ID: 27748816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.